This webinar is part of NAHEWD's national series Bridging HIV and SUD: Innovations in the Field. The series is highlighting various innovative models and approaches to treating substance use disorder (SUD) in people at risk for and living with HIV. This webinar will explore promising clinical trials of psychedelic-assisted therapies, the potential of approved psilocybin and MDMA-assisted treatments for anxiety, mood, and SUDs. Clinicians interested in new mental healthcare treatment options for SUDs can learn about current treatment designs and published study outcomes to consider how psychedelic-assisted therapies might serve people at risk for and living with HIV.
Event Location: Virtual
Contact & Accommodations
Opioid Response Network: orn@aaap.org